Huvepharma, Inc. Issues Voluntary Nationwide Recall of Duramycin-10 Due to Stability Failure

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

Huvepharma, Inc. Issues Voluntary Nationwide Recall of Duramycin-10 Due to Stability Failure

12/28/2016 05:56 PM EST

Longmont, Colorado, Huvepharma, Inc., which recently acquired the Longmont Colorado manufacturing facility including the respective FDA registration associated with this recall, is voluntarily recalling 1 lot of Duramycin-10 Soluble Powder, distributed by Durvet, to the consumer level. The product had a stability failure at the 48 month time point. Risk Statement: The product does not have the potential to result in a health risk to any animals that are indicated for use.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)